Fundraising Fox

Argonaute

Cardiff, GB · 1 known investors

argonauterna.com ↗

Argonaute RNA develops siRNA-based therapeutics for cardiometabolic and other diseases, using proprietary PULSE siRNA and dual siRNA platform technologies to inhibit specific gene expression. The company targets pharmaceutical partners and operates in precision medicine for treating complex, multi-factorial diseases.

BiotechDigital Healthin /argonaute-rna-limited

Founders & leadership

M
MikeinCEO
AP
Anthony ParkerinCo-founder

Investors · 1

Oxford Investment Opportunity Network (OION)Oxford · $190K – $2.5M